DJ-1 Plays an Important Role in Homoharringtonine-Induced Apoptosis of Imatinib-Resistant Chronic Myeloid Leukemia Cells

被引：0
|
作者：
Zhou, Xuan [1 ]
Xu, Na [1 ]
Li, Rong [2 ]
Li, Lin [1 ]
Ding, Li [1 ]
Lu, Qisi [1 ]
Li, Yulin [3 ]
Liu Xiaoli [1 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients
    O Frank
    B Brors
    A Fabarius
    L Li
    M Haak
    S Merk
    U Schwindel
    C Zheng
    M C Müller
    N Gretz
    R Hehlmann
    A Hochhaus
    W Seifarth
    Leukemia, 2006, 20 : 1400 - 1407
  • [22] Biology of Chronic Myeloid Leukemia and Possible Therapeutic Approaches to Imatinib-Resistant Disease
    Chikashi Yoshida
    Junia V. Melo
    International Journal of Hematology, 2004, 79 : 420 - 433
  • [23] Bcl-xL Is a Dominant Antiapoptotic Protein that Inhibits Homoharringtonine-Induced Apoptosis in Leukemia Cells
    Yin, Shiliang
    Wang, Rui
    Zhou, Fan
    Zhang, Hong
    Jing, Yongkui
    MOLECULAR PHARMACOLOGY, 2011, 79 (06) : 1072 - 1083
  • [24] The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells
    Bozkurt, Sureyya
    Ozkan, Tulin
    Ozmen, Fusun
    Baran, Yusuf
    Sunguroglu, Asuman
    Kansu, Emin
    HEMATOLOGY, 2013, 18 (04) : 217 - 223
  • [25] Identification of nilotinib-altered microRNA expression patterns in imatinib-resistant chronic myeloid leukemia cells
    You, Ren-In
    Ho, Ching-Liang
    Hung, Hsiu-Man
    Chao, Tsu-Yi
    BIOMARKERS AND GENOMIC MEDICINE, 2013, 5 (03) : 71 - 73
  • [26] Enhancement of imatinib-induced apoptosis through catalase activity modulation in imatinib-resistant chronic myelogenous leukemia blastic phase cells.
    Kwee, Jolie Kiemlian
    dos Santos-Ferreira, Ana Carolina
    Gomes Luque, Diogo
    da Cunha Vasconcelos, Flavia
    Silva, Karina Lani
    Klumb, Claudete Esteves
    Maia, Raquel Ciuvalschi
    Chiattone, Carlos
    BLOOD, 2006, 108 (11) : 174B - 174B
  • [27] Characteristics of Dasatinib- and Imatinib-Resistant Chronic Myelogenous Leukemia Cells
    Okabe, Seiichi
    Tauchi, Tetsuzo
    Ohyashiki, Kazuma
    CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6181 - 6186
  • [28] Synergistic killing effect of imatinib and simvastatin on imatinib-resistant chronic myelogenous leukemia cells
    Oh, Bora
    Kim, Tae Y.
    Min, Hyun J.
    Kim, Miyoung
    Kang, Myung S.
    Huh, Ji Y.
    Kim, Youngsoo
    Lee, Dong S.
    ANTI-CANCER DRUGS, 2013, 24 (01) : 20 - 31
  • [29] Distinct Dasatinib-Induced Mechanisms of Apoptotic Response and Exosome Release in Imatinib-Resistant Human Chronic Myeloid Leukemia Cells
    Liu, Juan
    Zhang, Yujing
    Liu, Aichun
    Wang, Jinghua
    Li, Lianqiao
    Chen, Xi
    Gao, Xinyu
    Xue, Yanming
    Zhang, Xiaomin
    Liu, Yao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (04):
  • [30] Targeting lysosomes to eradicate imatinib-resistant chronic myelogenous leukemia cells
    Puissant, A.
    Dufies, M.
    Raynaud, S.
    Cassuto, J-P
    Auberger, P.
    LEUKEMIA, 2010, 24 (05) : 1099 - 1101
12345